Stifel Financial Corp Mirati Therapeutics, Inc. Transaction History

Stifel Financial Corp

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$41.99 - $62.38 $883,637 - $1.31 Million	-21,044 Reduced 77.61%	6,071 $356,000
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $144,059 - $235,003	5,182 Added 23.63%	27,115 $1.18 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $32,589 - $44,639	902 Added 4.29%	21,933 $792,000
Q1 2023 May 12, 2023	SELL	$36.54 - $54.26 $154,125 - $228,868	-4,218 Reduced 16.71%	21,031 $781,000
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $532,960 - $1.27 Million	12,914 Added 104.69%	25,249 $1.14 Million

Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $4,165 - $6,069	-70 Reduced 0.56%	12,335 $861,000
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $234,294 - $530,751	5,983 Added 93.16%	12,405 $833,000
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $486,916 - $969,529	6,422 New	6,422 $528,000
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $161,580 - $232,914	-1,224 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $161,727 - $217,198	1,224 New	1,224 $217,000
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $176,560 - $246,208	-1,111 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $180,037 - $266,939	1,111 New	1,111 $244,000
Q3 2019 Nov 13, 2019	SELL	$77.91 - $109.6 $282,657 - $397,628	-3,628 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $215,829 - $379,887	3,628 New	3,628 $375,000
Q4 2018 Feb 13, 2019	SELL	$32.0 - $47.43 $160,000 - $237,150	-5,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$47.1 - $62.7 $235,500 - $313,500	5,000 New	5,000 $236,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.